SeaStar Medical Files 8-K on Financials

TL;DR

SeaStar Medical dropped an 8-K detailing their financial condition and operations.

AI Summary

SeaStar Medical Holding Corp. filed an 8-K on April 17, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing also notes the company's incorporation in Delaware and its principal executive offices located at 3513 Brighton Blvd., Suite 410, Denver, Colorado.

Why It Matters

This filing provides investors with crucial updates on SeaStar Medical's financial performance and operational status, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.

Key Players & Entities

• SeaStar Medical Holding Corp. (company) — Registrant
• April 17, 2024 (date) — Date of Report
• 3513 Brighton Blvd., Suite 410, Denver, Colorado 80216 (location) — Principal Executive Offices
• LMF Acquisition Opportunities Inc (company) — Former Company Name

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock par value $0.0001 per share ICU NASDAQ Warrants, ea
• $11.50 — sable for one share of Common Stock for $11.50 per share ICUCW NASDAQ Indicate b

Filing Documents

• a8k.htm (8-K) — 29KB
• exhibit99-1.htm (EX-99.1) — 211KB
• image0.jpg (GRAPHIC) — 1KB
• seastar_logo.jpg (GRAPHIC) — 20KB
• 0000929638-24-001513.txt ( ) — 445KB
• icu-20240417.xsd (EX-101.SCH) — 4KB
• icu-20240417_def.xml (EX-101.DEF) — 18KB
• icu-20240417_lab.xml (EX-101.LAB) — 26KB
• icu-20240417_pre.xml (EX-101.PRE) — 20KB
• a8k_htm.xml (XML) — 6KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On April 17, 2024, SeaStar Medical Holding Corporation (the "Company") issued a press release (the "Press Release") announcing its financial results for the twelve months ended December 31, 2023 and an update on the Company's operations. The Company is furnishing a copy of the Press Release, which is attached hereto as Exhibit 99.1. The information provided in this Item 2.02 (including Exhibit 99.1) of this Current Report on Form 8-K is being furnished and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in this Current Report shall not be deemed to be incorporated by reference in any filing made by the Company pursuant to the Securities Act of 1933, as amended, or the Exchange Act, other than to the extent that such filing incorporated by reference any or all of such information by express reference thereto.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description Exhibit 99.1 Press Release dated April 17, 2024 Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SeaStar Medical Holding Corporation Date: April 17, 2024 By: /s/ Eric Schlorff Eric Schlorff Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR